您的位置: 首页 > 农业专利 > 详情页

Combination of angiopoietin-2 antagonist and of VEGF-A, KDR and/or Flt1 antagonist for treating cancer
专利权人:
MedImmune Limited
发明人:
Brown, Jeffrey Lester,Emery, Stephen Charles,Blakey, David Charles
申请号:
AU2011201326
公开号:
AU2011201326B2
申请日:
2011.03.23
申请国别(地区):
AU
年份:
2012
代理人:
摘要:
#$%^&*AU2011201326B220120112.pdf#####C: NRPortbl DCC AMT 354651 11 DOC-22/03/2011 ABSTRACT "Combination of angiopoietin-2 antagonist and of VEGF-A, KDR and/or FtI antagonist for treating cancer" The invention relates to agents which possess anti-angiogenic activity and are accordingly useful in methods of treatment of disease states associated with angiogenesis in the animal or human body. More specifically the invention concerns a combination of an antagonist of the biological activity of Angiopoietin-2 and an antagonist of the biological activity of VEGF-A, and/or KDR, and/or Fltl, and uses of such antagonists.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充